Table 2.
Pharmacokinetic models and sedation algorithms used in published studies. Terms are defined as follows: Starting concentration, the concentration of propofol at which participants commence the sedation regime; Increment concentration, the increase applied to the target-site concentration of propofol obtained by each participant handheld trigger activation; Lock-out time, the time after an increment in target-site concentration during which a subsequent handheld trigger activation will not cause a further increment; Maximum obtainable concentration, the ‘ceiling’ target-site concentration, above which the sedation will not increment regardless of handheld trigger activations; Decrement concentration, the target-site concentration reduction which is automatically applied in the event of no handheld trigger activations within the decrement time; Decrement time, the time which must expire with no handheld trigger activations before the decrement concentration is automatically applied; Minimum concentration, the target-site concentration below which the sedation will not decrement during the sedation period.
| Authors | Year | Propofol model | Target-site | Starting concentration (μg ml−1) | Increment concentration (μg ml−1) | Lock-out (sec) | Maximum obtainable concentration (μg ml−1) | Decrement concentration (μg ml−1) | Decrement time (s) | Minimum concentration (μg ml−1) |
|---|---|---|---|---|---|---|---|---|---|---|
| Irwin and colleagues8 | 1997 | Marsh | Plasma | 1.0 | 0.2 | 120 | 3.0 | 0.2 | Variable | 0.2 |
| Murdoch and Kenny9 | 1999 | Marsh | Plasma | 1.0 | 0.2 | 120 | 3.0 | Unspecified | 360 | 0.2 |
| Murdoch and colleagues10 | 2000 | Marsh | Plasma | 1.0 | 0.2 | 120 | 3.0 | Unspecified | 360 | 0.2 |
| Gillham and colleagues11 | 2001 | Marsh | Plasma | 1.0 | 0.2 | 120 | 3.0 | 0.2 | 360 | Unspecified |
| Henderson and colleagues12 | 2002 | Marsh | Plasma | 0.5 | 0.1 | 240 | 3.0 | Unspecified | Unspecified | Unspecified |
| Leitch and colleagues13 | 2003 | Marsh | Plasma | 1.0 | 0.2 | 120 | 3.0 | 0.2 | 360 | Unspecified |
| Rodrigo and colleagues14 | 2003 | Marsh | Plasma | 1.4 | 0.2 | 120 | 3.0 | 0.2 | Variable | 0.2 |
| Campbell and colleagues15 | 2004 | Marsh | Plasma | 1.0 | 0.2 | 120 | 4.5 | Unspecified | Unspecified | Unspecified |
| Leitch and colleagues16 | 2004 | Marsh | Plasma | 1.0 | 0.2 | 120 | 3.0 | Unspecified | 360 | Unspecified |
| Rodrigo and colleagues17 | 2004 | Marsh | Plasma | 1.4 | 0.2 | 120 | 3.0 | 0.2 | Variable | 0.2 |
| Anderson and colleagues18 | 2005 | Marsh | Effect-site | 1.0 | 0.2 | Variable | No maximum | 0.2 | 360 | Unspecified |
| Chapman and colleagues19 | 2006 | Marsh | Effect-site | 1.0 | 0.2 | Variable | No maximum | No decrement | N/A | Unspecified |
| Stonell and colleagues20 | 2006 | Schnider | Effect-site | 0.8 | 0.1 | 180 | No maximum | 0.1 | 300 | Unspecified |
| Allam and colleagues21 | 2013 | Marsh | Effect-site | 1.0 | 0.2 | Variable | 3.0 | Variable | Variable | Unspecified |
| O'Brien and colleagues22 | 2013 | Marsh | Effect-site | 1.0 | 0.2 | Variable | 3.0 | No decrement | N/A | Unspecified |
| Hewson and colleagues23 | 2019 | Schnider | Effect-site | 0.5 | 0.2 | Variable | 2.0 | 0.1 | 360 | 0.5 |
| Hewson and colleagues24 | 2019 | Schnider | Effect-site | 0.5 | 0.2 | 120 | 2.0 | 0.1 | 900 | 0.5 |